Literature DB >> 24965973

COMT 158G/A and CYP1B1 432C/G polymorphisms increase the risk of endometriosis and adenomyosis: a meta-analysis.

Xiang Tong1, Zhenzhen Li1, Yao Wu1, Xiaowei Fu1, Yonggang Zhang2, Hong Fan3.   

Abstract

OBJECTIVE: Catechol-O-methyltransferase (COMT) 158G/A and cytochrome P450-1B1 (CYP1B1) 432C/G gene polymorphisms have been associated with the risk of endometriosis and adenomyosis, but results remain inconclusive. The aim of this study was to investigate the relationships between these polymorphisms and the risk of endometriosis and adenomyosis by meta-analysis. STUDY
DESIGN: A search was performed using PubMed, Embase, the Chinese Journals Full-text Database and Wanfang databases up to September 2013. Odds ratios (OR) and 95% confidence intervals (95% CI) were used to evaluate the relationships. Statistical analyses were undertaken using STATA Version 11.0.
RESULTS: The literature search identified 10 articles, involving 1770 cases and 2057 controls. The two polymorphisms were found to be significantly associated with the risk of endometriosis and adenomyosis (COMT 158 G/A: AA+AG vs GG: OR 1.20, 95% CI 1.01-1.43; CYP1B1 432 C/G: GG+GC vs CC: OR 1.28, 95% CI 1.01-1.68). In the subgroup analysis by ethnicity, the two polymorphisms were significantly associated with the risk of endometriosis and adenomyosis among Asian populations but not among Caucasian populations.
CONCLUSIONS: COMT 158G/A and CYP1B1 432C/G polymorphisms may contribute to the risk of endometriosis and adenomyosis, particularly in Asian populations. Larger studies are required to evaluate this association further.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adenomyosis; CYP1B1; Endometriosis; Meta-analysis

Mesh:

Substances:

Year:  2014        PMID: 24965973     DOI: 10.1016/j.ejogrb.2014.04.039

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  Aberrant endometrial DNA methylome of homeobox A10 and catechol-O-methyltransferase in endometriosis.

Authors:  Fei Ji; Xinhua Yang; Yan He; Hui Wang; Aixingzi Aili; Yan Ding
Journal:  J Assist Reprod Genet       Date:  2017-01-10       Impact factor: 3.412

2.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

3.  Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.

Authors:  Hui Ye; Yazhou He; Jiarong Wang; Tiange Song; Zhu Lan; Yiqi Zhao; Mingrong Xi
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

Review 4.  Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility.

Authors:  Khaleque N Khan; Akira Fujishita; Taisuke Mori
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

5.  Analysis of the relationship between COMT polymorphisms and endometriosis susceptibility.

Authors:  Jiajia Zhai; Lei Jiang; Aiping Wen; Jingde Jia; Lili Zhu; Bo Fan
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

6.  Epidemiological aspects of the outcomes from the treatment of endometriosis: Experience from two different geographical areas.

Authors:  Charoula Matalliotaki; Michail Matalliotakis; Maria I Zervou; Athina Patelarou; Ioannis Koliarakis; Demetrios A Spandidos; Aydin Arici; Ioannis Matalliotakis; George N Goulielmos
Journal:  Exp Ther Med       Date:  2019-12-05       Impact factor: 2.447

7.  NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis.

Authors:  Zhangming Wei; Mengmeng Zhang; Xinyue Zhang; Mingyu Yi; Xiaomeng Xia; Xiaoling Fang
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.